Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease
Public ClinicalTrials.gov record NCT01559129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety, tolerability, and efficacy of pomalidomide in the treatment of patients with systemic sclerosis with interstitial lung disease.
Study identification
- NCT ID
- NCT01559129
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2012 (Actual)
- Primary completion
- Nov 3, 2016 (Actual)
- Completion
- Nov 3, 2016 (Actual)
- Last update posted
- Dec 1, 2023
2012 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Division of Rheumatology | Los Angeles | California | 90095 | — |
| Advances in Medicine | Rancho Mirage | California | 92270 | — |
| Delaware Medical Care Associates, LLC | Newark | Delaware | 19713 | — |
| Georgetown University School of Medicine | Washington D.C. | District of Columbia | 20057 | — |
| USF Health Faculty Office Building-FOB | Tampa | Florida | 33612 | — |
| Arthritis Research and Treatment Center | Stockbridge | Georgia | 30281 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| LaPorte County Institute for Clinical Research, Inc | Michigan City | Indiana | 46360 | — |
| University of Kentucky | Lexington | Kentucky | 40536-0284 | — |
| Louisiana State University | Shreveport | Louisiana | 71103 | — |
| Boston University of Medicine BUMC | Boston | Massachusetts | 02118 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| UMDNJ-Robert Wood Johnson Medical School Clinical Research Center | New Brunswick | New Jersey | 08903 | — |
| North Shore-LIJ Health System-Division of Rheumatology | Great Neck | New York | 11021 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Toledo College of Medicine | Toledo | Ohio | 43614 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01559129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2023 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01559129 live on ClinicalTrials.gov.